Innovative pharmaceutical sector fluctuates and adjusts, more than 10 billion yuan of funds enter the market through ETFs.

Recently, the innovative pharmaceutical sector has experienced some fluctuations, while at the same time, funds have actively entered through ETFs. Since August, over 100 billion yuan has flowed into thematic ETFs for innovative pharmaceuticals, with the shares of many ETFs reaching new highs since their listing. In addition, some actively managed equity funds heavily invested in the innovative pharmaceutical sector have imposed restrictions on purchases. The future investment opportunities in the innovative pharmaceutical sector have also become a focus of market attention. Several fund managers have stated that the sector has great long-term growth potential, but due to recent gains, it is important to focus on stocks with strong fundamentals.